On May 2, 2025, Adial Pharmaceuticals, Inc. entered into an agreement allowing a holder to exercise existing warrants for 3,718,440 shares at a reduced price of $0.74 each, raising approximately $2.75 million for the company. The transactions closed on May 5, 2025, with new warrants also being issued as part of the deal.